Gary Dahl

Professor of Pediatrics (Hematology/Oncology) at the Lucile Salter Packard Children's Hospital

Professional Education

Board Certification: Pediatrics, American Board of Pediatrics (1976)

Fellowship: St Jude Children's Research Hospital (1976) TN

Internship: University of Oregon (1968) OR

Residency: University of Oregon (1974) OR

Board Certification: Pediatric Hematology-Oncology, American Board of Pediatrics (1976)

Medical Education: University of Oregon Medical School (1967) OR

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Altered Resting State Functional Connectivity in Young Survivors of Acute Lymphoblastic Leukemia
Kesler, S. R., Gugel, M., Pritchard-Berman, M., Lee, C., Kutner, E., & Lacayo, N. (2014). Altered Resting State Functional Connectivity in Young Survivors of Acute Lymphoblastic Leukemia. PEDIATRIC BLOOD & CANCER, 61(7), 1295-1299.

Genomic ancestry and somatic alterations correlate with age at diagnosis in Hispanic children with B-cell acute lymphoblastic leukemia
Walsh, K. M., de Smith, A. J., Welch, T. C., Smirnov, I., Cunningham, M. J., & Wiemels, J. L. (2014). Genomic ancestry and somatic alterations correlate with age at diagnosis in Hispanic children with B-cell acute lymphoblastic leukemia. AMERICAN JOURNAL OF HEMATOLOGY, 89(7), 721-725.

Safety Profile of Asparaginase Erwinia chrysanthemi in a Large Compassionate-Use Trial
Plourde, P. V., Jeha, S., Hijiya, N., Keller, F. G., Silverman, L. B., & Corn, T. (2014). Safety Profile of Asparaginase Erwinia chrysanthemi in a Large Compassionate-Use Trial. PEDIATRIC BLOOD & CANCER, 61(7), 1232-1238.

Gemtuzumab Ozogamicin Can Reduce Minimal Residual Disease in Patients With Childhood Acute Myeloid Leukemia
O'Hear, C., Inaba, H., Pounds, S., Shi, L., Dahl, G., & Rubnitz, J. E. (2013). Gemtuzumab Ozogamicin Can Reduce Minimal Residual Disease in Patients With Childhood Acute Myeloid Leukemia. CANCER, 119(22), 4036-4043.

Development and validation of a single-cell network profiling assay-based classifier to predict response to induction therapy in paediatric patients with de novo acute myeloid leukaemia: a report from the Children's Oncology Group
Lacayo, N. J., Alonzo, T. A., Gayko, U., Rosen, D. B., Westfall, M., & Meshinchi, S. (2013). Development and validation of a single-cell network profiling assay-based classifier to predict response to induction therapy in paediatric patients with de novo acute myeloid leukaemia: a report from the Children's Oncology Group. BRITISH JOURNAL OF HAEMATOLOGY, 162(2), 250-262.

Pediatric Acute Myeloid Leukemia as Classified Using 2008 WHO Criteria A Single-Center Experience
Davis, K. L., Marina, N., Arber, D. A., Ma, L., Cherry, A., & Heerema-McKenney, A. (2013). Pediatric Acute Myeloid Leukemia as Classified Using 2008 WHO Criteria A Single-Center Experience. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 139(6), 818-825.

Prognostic features in acute megakaryoblastic leukemia in children without Down syndrome: a report from the AML02 multicenter trial and the Children's Oncology Group Study POG 9421
O'Brien, M. M., Cao, X., Pounds, S., Dahl, G. V., Raimondi, S. C., & Rubnitz, J. E. (2013). Prognostic features in acute megakaryoblastic leukemia in children without Down syndrome: a report from the AML02 multicenter trial and the Children's Oncology Group Study POG 9421. LEUKEMIA, 27(3), 731-734.

Treatment Outcome in Older Patients With Childhood Acute Myeloid Leukemia
Rubnitz, J. E., Pounds, S., Cao, X., Jenkins, L., Dahl, G., & Inaba, H. (2012). Treatment Outcome in Older Patients With Childhood Acute Myeloid Leukemia. CANCER, 118(24), 6253-6259.

Effect of body mass index on the outcome of children with acute myeloid leukemia
Inaba, H., Surprise, H. C., Pounds, S., Cao, X., Howard, S. C., & Rubnitz, J. E. (2012). Effect of body mass index on the outcome of children with acute myeloid leukemia. CANCER, 118(23), 5989-5996.

Massive evolution of the immunoglobulin heavy chain locus in children with B precursor acute lymphoblastic leukemia
Gawad, C., Pepin, F., Carlton, V. Eh., Klinger, M., Logan, A. C., & Lacayo, N. (2012). Massive evolution of the immunoglobulin heavy chain locus in children with B precursor acute lymphoblastic leukemia. BLOOD, 120(22), 4407-4417.

Concurrent cyclophosphamide and craniospinal radiotherapy for pediatric high-risk embryonal brain tumors
Campen, C. J., Dearlove, J., Partap, S., Murphy, P., Gibbs, I. C., & Fisher, P. G. (2012). Concurrent cyclophosphamide and craniospinal radiotherapy for pediatric high-risk embryonal brain tumors. JOURNAL OF NEURO-ONCOLOGY, 110(2), 287-291.

HLA-DP genetic variation, proxies for early life immune modulation and childhood acute lymphoblastic leukemia risk
Urayama, K. Y., Chokkalingam, A. P., Metayer, C., Ma, X., Selvin, S., & Buffler, P. A. (2012). HLA-DP genetic variation, proxies for early life immune modulation and childhood acute lymphoblastic leukemia risk. BLOOD, 120(15), 3039-3047.

Comparative Analysis of Different Approaches to Measure Treatment Response in Acute Myeloid Leukemia
Inaba, H., Coustan-Smith, E., Cao, X., Pounds, S. B., Shurtleff, S. A., & Campana, D. (2012). Comparative Analysis of Different Approaches to Measure Treatment Response in Acute Myeloid Leukemia. JOURNAL OF CLINICAL ONCOLOGY, 30(29), 3625-3632.

Variation in xenobiotic transport and metabolism genes, household chemical exposures, and risk of childhood acute lymphoblastic leukemia
Chokkalingam, A. P., Metayer, C., Scelo, G. A., Chang, J. S., Urayama, K. Y., & Buffler, P. A. (2012). Variation in xenobiotic transport and metabolism genes, household chemical exposures, and risk of childhood acute lymphoblastic leukemia. CANCER CAUSES & CONTROL, 23(8), 1367-1375.

Phase II study of 2-chlorodeoxyadenosine plus idarubicin for children with acute myeloid leukaemia in first relapse: a Paediatric Oncology Group study
Chaleff, S., Hurwitz, C. A., Chang, M., Dahl, G., Alonzo, T. A., & Weinstein, H. (2012). Phase II study of 2-chlorodeoxyadenosine plus idarubicin for children with acute myeloid leukaemia in first relapse: a Paediatric Oncology Group study. BRITISH JOURNAL OF HAEMATOLOGY, 156(5), 649-655.

Therapeutic Complications in a Patient With High-Risk Acute Lymphoblastic Leukemia and Undiagnosed Hereditary Hemochromatosis
Balagtas, J. M. S., & Dahl, G. V. (2012). Therapeutic Complications in a Patient With High-Risk Acute Lymphoblastic Leukemia and Undiagnosed Hereditary Hemochromatosis. PEDIATRIC BLOOD & CANCER, 58(1), 101-103.

Langerhans cell histiocytosis in a 5-month-old presenting with biparietal masses Case report
Pricola, K. L., Karamchandani, J., Vogel, H., Dahl, G. V., Yeom, K. W., & Guzman, R. (2010). Langerhans cell histiocytosis in a 5-month-old presenting with biparietal masses Case report. JOURNAL OF NEUROSURGERY-PEDIATRICS, 6(4), 393-397.

Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial
Rubnitz, J. E., Inaba, H., Dahl, G., Ribeiro, R. C., Bowman, W. P., & Campana, D. (2010). Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trial. LANCET ONCOLOGY, 11(6), 543-552.

Concurrent Treatment of Steroid-Related Mood and Psychotic Symptoms With Risperidone
Ularntinon, S., Tzuang, D., Dahl, G., & Shaw, R. J. (2010). Concurrent Treatment of Steroid-Related Mood and Psychotic Symptoms With Risperidone. PEDIATRICS, 125(5), E1241-E1245.

Phase I Study of Valspodar (PSC-833) With Mitoxantrone and Etoposide in Refractory and Relapsed Pediatric Acute Leukemia: A Report From the Children's Oncology Group
O'Brien, M. M., Lacayo, N. J., Lum, B. L., Kshirsagar, S., Buck, S., & Dahl, G. V. (2010). Phase I Study of Valspodar (PSC-833) With Mitoxantrone and Etoposide in Refractory and Relapsed Pediatric Acute Leukemia: A Report From the Children's Oncology Group. PEDIATRIC BLOOD & CANCER, 54(5), 694-702.

WT1 Expression at Diagnosis Does Not Predict Survival in Pediatric AML: A Report From the Children's Oncology Group
Noronha, S. A., Farrar, J. E., Alonzo, T. A., Gerbing, R. B., Lacayo, N. J., & Loeb, D. M. (2009). WT1 Expression at Diagnosis Does Not Predict Survival in Pediatric AML: A Report From the Children's Oncology Group. PEDIATRIC BLOOD & CANCER, 53(6), 1136-1139.

Molecular inversion probes reveal patterns of 9p21 deletion and copy number aberrations in childhood leukemia
Schiffman, J. D., Wang, Y., McPherson, L. A., Welch, K., Zhang, N., & Ji, H. P. (2009). Molecular inversion probes reveal patterns of 9p21 deletion and copy number aberrations in childhood leukemia. CANCER GENETICS AND CYTOGENETICS, 193(1), 9-18.

Hematopoietic stem cell transplant for pediatric acute promyelocytic leukemia
Dvorak, C. C., Agarwal, R., Dahl, G. V., Gregory, J. J., & Feusner, J. H. (2008). Hematopoietic stem cell transplant for pediatric acute promyelocytic leukemia. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 14(7), 824-830.

Tissue microarrays from bone marrow aspirates for high-throughput assessment of immunohistologic markers in pediatric acute leukemia
Hazard, F. K., Zhao, S., Schiffman, J. D., Lacayo, N. J., Dahl, G. V., & Natkunam, Y. (2008). Tissue microarrays from bone marrow aspirates for high-throughput assessment of immunohistologic markers in pediatric acute leukemia. PEDIATRIC AND DEVELOPMENTAL PATHOLOGY, 11(4), 283-290.

Comparison of antitumor effects of multitargeted tyrosine kinase inhibitors in acute myelogenous leukemia
Hu, S., Niu, H., Minkin, P., Orwick, S., Shimada, A., & Baker, S. D. (2008). Comparison of antitumor effects of multitargeted tyrosine kinase inhibitors in acute myelogenous leukemia. MOLECULAR CANCER THERAPEUTICS, 7(5), 1110-1120.

Identification of a novel p53 in-frame deletion in a Li-Fraumeni-like family
Schiffman, J. D., Chun, N., Fisher, P. G., Dahl, G. V., Ford, J. M., & Eggerding, F. A. (2008). Identification of a novel p53 in-frame deletion in a Li-Fraumeni-like family. PEDIATRIC BLOOD & CANCER, 50(4), 914-916.

Cardiomyopathy in children with down syndrome treated for acute myeloid leukemia: A report from the children's oncology group study POG 9421
O'Brien, M. M., Taub, J. W., Chang, M. N., Massey, G. V., Stine, K. C., & Dahl, G. V. (2008). Cardiomyopathy in children with down syndrome treated for acute myeloid leukemia: A report from the children's oncology group study POG 9421. JOURNAL OF CLINICAL ONCOLOGY, 26(3), 414-420.

Concerns about infertility risks among pediatric oncology patients and their parents
Oosterhuis, B. E., Goodwin, T., Kiernan, M., Hudson, M. M., & Dahl, G. V. (2008). Concerns about infertility risks among pediatric oncology patients and their parents. PEDIATRIC BLOOD & CANCER, 50(1), 85-89.

Outcomes of transplantation in children with primary hepatic malignancy
Beaunoyer, M., Vanatta, J. M., Oyihara, M., Strichartz, D., Dahl, G., & Esquivel, C. O. (2007). Outcomes of transplantation in children with primary hepatic malignancy. PEDIATRIC TRANSPLANTATION, 11(6), 655-660.

Reinduction of relapsed acute promyelocytic leukemia with ATRA and low dose anti metabolite-based chemotherapy
Dvorak, C. C., Sanders, R. P., Dahl, G. Vh., Donaldson, S. S., & Razzouk, B. I. (2007). Reinduction of relapsed acute promyelocytic leukemia with ATRA and low dose anti metabolite-based chemotherapy. PEDIATRIC BLOOD & CANCER, 48(5), 582-585.

A syndrome of irreversible leukoencephalopathy following pediatric allogeneic bone marrow transplantation
Minn, A. Y., Fisher, P. G., Barnes, P. D., & Dahl, G. V. (2007). A syndrome of irreversible leukoencephalopathy following pediatric allogeneic bone marrow transplantation. PEDIATRIC BLOOD & CANCER, 48(2), 213-217.

Attitudes and practices of pediatric oncology providers regarding fertility issues
Goodwin, T., Oosterhuis, B. E., Kiernan, M., Hudson, M. A., & Dahl, G. V. (2007). Attitudes and practices of pediatric oncology providers regarding fertility issues. PEDIATRIC BLOOD & CANCER, 48(1), 80-85.

CpG island methylator phenotype and childhood leukemia
Lacayo, N. J., Di Martino, J. F., Wei, M. C., & Dahl, G. V. (2006). CpG island methylator phenotype and childhood leukemia. CLINICAL CANCER RESEARCH, 12(16), 4787-4789.

A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children's Oncology Group (COG) study POG-9481
Massey, G. V., Zipursky, A., Chang, M. N., Doyle, J. J., Nasim, S., & Weinstein, H. J. (2006). A prospective study of the natural history of transient leukemia (TL) in neonates with Down syndrome (DS): Children's Oncology Group (COG) study POG-9481. BLOOD, 107(12), 4606-4613.

Low or absent SPARC expression in acute myeloid leukemia with MLL rearrangements is associated with sensitivity to growth inhibition by exogenous SPARC protein
DiMartino, J. F., Lacayo, N. J., Varadi, M., Li, L., Saraiya, C., & Dahl, G. (2006). Low or absent SPARC expression in acute myeloid leukemia with MLL rearrangements is associated with sensitivity to growth inhibition by exogenous SPARC protein. LEUKEMIA, 20(3), 426-432.

Anthracyclines cause endothelial injury in pediatric cancer patients: A pilot study
Chow, A. Y., Chin, C., Dahl, G., & Rosenthal, D. N. (2006). Anthracyclines cause endothelial injury in pediatric cancer patients: A pilot study. JOURNAL OF CLINICAL ONCOLOGY, 24(6), 925-928.

Randomized use of cyclosporin A (CsA) to modulate P-glycoprotein in children with AML in remission: Pediatric Oncology Group Study 9421
Becton, D., Dahl, G. V., Ravindranath, Y., Chang, M. N., Behm, F. G., & Weinstein, H. (2006). Randomized use of cyclosporin A (CsA) to modulate P-glycoprotein in children with AML in remission: Pediatric Oncology Group Study 9421. BLOOD, 107(4), 1315-1324.

Profile of daily life in children with brain tumors: An assessment of health-related quality of life
Bhat, S. R., Goodwin, T. L., Burwinkle, T. M., Lansdale, M. F., Dahl, G. V., & Fisher, P. G. (2005). Profile of daily life in children with brain tumors: An assessment of health-related quality of life. JOURNAL OF CLINICAL ONCOLOGY, 23(24), 5493-5500.

Gene expression profiles at diagnosis in de novo childhood AML patients identify FLT3 mutations with good clinical outcomes
Lacayo, N. J., Meshinchi, S., Kinnunen, P., Yu, R., Wang, Y., & Dahl, G. V. (2004). Gene expression profiles at diagnosis in de novo childhood AML patients identify FLT3 mutations with good clinical outcomes. BLOOD, 104(9), 2646-2654.

Phase I trial of intrathecal liposomal cytarabine in children with neoplastic meningitis
Bomgaars, L., Geyer, J. R., Franklin, J., Dahl, G., Park, J., & BLANEY, S. M. (2004). Phase I trial of intrathecal liposomal cytarabine in children with neoplastic meningitis. JOURNAL OF CLINICAL ONCOLOGY, 22(19), 3916-3921.

Critical windows of exposure to household pesticides and risk of childhood leukemia
Ma, X. M., Buffler, P. A., Gunier, R. B., Dahl, G., Smith, M. T., & Reynolds, P. (2002). Critical windows of exposure to household pesticides and risk of childhood leukemia. ENVIRONMENTAL HEALTH PERSPECTIVES, 110(9), 955-960.

Pharmacokinetic interactions of cyclosporine with etoposide and mitoxantrone in children with acute myeloid leukemia
Lacayo, N. J., Lum, B. L., Becton, D. L., Weinstein, H., Ravindranath, Y., & Dahl, G. V. (2002). Pharmacokinetic interactions of cyclosporine with etoposide and mitoxantrone in children with acute myeloid leukemia. LEUKEMIA, 16(5), 920-927.

Surveillance neuroimaging to detect relapse in childhood brain tumors: A pediatric oncology group study
Minn, A. Y., Pollock, B. H., Garzarella, L., Dahl, G. V., Kun, L. E., & Fisher, P. G. (2001). Surveillance neuroimaging to detect relapse in childhood brain tumors: A pediatric oncology group study. JOURNAL OF CLINICAL ONCOLOGY, 19(21), 4135-4140.

Modified cyclophosphamide, hydroxydaunorubicin, vincristine, and prednisone therapy for posttransplantation lymphoproliferative disease in pediatric patients undergoing solid organ transplantation
Suryanarayan, K., Natkunam, Y., Berry, G., Bangs, C. D., Cherry, A., & Dahl, G. (2001). Modified cyclophosphamide, hydroxydaunorubicin, vincristine, and prednisone therapy for posttransplantation lymphoproliferative disease in pediatric patients undergoing solid organ transplantation. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 23(7), 452-455.

Weekly dosing of carboplatin increases risk of allergy in children
Yu, D. Y., Dahl, G. Vh., Shames, R. S., & Fisher, P. G. (2001). Weekly dosing of carboplatin increases risk of allergy in children. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 23(6), 349-352.

Management of children with metastatic spinal myxopapillary ependymoma using craniospinal irradiation
Chinn, D. M., Donaldson, S. S., Dahl, G. V., Wilson, J. D., Huhn, S. L., & Fisher, P. C. (2000). Management of children with metastatic spinal myxopapillary ependymoma using craniospinal irradiation. MEDICAL AND PEDIATRIC ONCOLOGY, 35(4), 443-445.

Mitoxantrone, etoposide, and cyclosporine therapy in pediatric patients with recurrent or refractory acute myeloid leukemia
Dahl, G. V., Lacayo, N. J., Brophy, N., Dunussi-Joannopoulos, K., Weinstein, H. J., & Arceci, R. J. (2000). Mitoxantrone, etoposide, and cyclosporine therapy in pediatric patients with recurrent or refractory acute myeloid leukemia. JOURNAL OF CLINICAL ONCOLOGY, 18(9), 1867-1875.

A multi-institutional retrospective study of intracranial ependymoma in children: Identification of risk factors
Horn, B., Heideman, R., Geyer, R., Pollack, I., Packer, R., & Russo, C. (1999). A multi-institutional retrospective study of intracranial ependymoma in children: Identification of risk factors. JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 21(3), 203-211.

Bcl-2 expression does not correlate with patient outcome in pediatric acute myelogenous leukemia
Naumovski, L., Martinovsky, G., Wong, C., Chang, M., Ravendranath, Y., & Dahl, G. (1998). Bcl-2 expression does not correlate with patient outcome in pediatric acute myelogenous leukemia. LEUKEMIA RESEARCH, 22(1), 81-87.

Neoplastic disorders after pediatric heart transplantation.
Bernstein, D., Baum, D., Berry, G., Dahl, G., Weiss, L., & Stinson, E. B. (1993). Neoplastic disorders after pediatric heart transplantation. Circulation, 88(5), II230-7.